The second coming of epigenetic drugs: a more strategic and broader research framework could boost the development of new drugs to modify epigenetic factors and gene expression.

Philip Hunter

doi:10.15252/embr.201540121

The second coming of epigenetic drugs: a more strategic and broader research framework could boost the development of new drugs to modify epigenetic factors and gene expression.

Philip Hunter

Open Access

PDF Available

https://doi.org/10.15252/embr.201540121

Copy DOI

Export

Save

Cite

Journal: EMBO reports	Publication Date: Feb 6, 2015
Citations: 20

#Bromodomain And Extra-terminal #Epigenetic Drug #Epigenetic Drug Discovery #Structure Of Target #Fluctuations In Gene Expression #Universities Of Toronto #Bromodomain And Extra-terminal Inhibitors #Epigenetic Switch #Specific Drug #Epigenetic Mechanisms

Abstract
Full-Text PDF
Similar Papers

Abstract

Listen

The second coming of epigenetic drugs: a more strategic and broader research framework could boost the development of new drugs to modify epigenetic factors and gene expression.

Full Text

Published Version (Free)

View/Download pdf

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: EMBO reports

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.

R Discovery Prime

The second coming of epigenetic drugs: a more strategic and broader research framework could boost the development of new drugs to modify epigenetic factors and gene expression.